BCAB vs PNR · $5.9M cap vs P/E 18, rev $4.18B
Bioatla Inc (BCAB) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
BCAB does not have a complete income-statement cache yet.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
BCAB currently screens at market cap $5.9M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the BCAB and PNR stock pages for the full models.
Not investment advice.